tiprankstipranks
Engene Holdings Inc. (ENGN)
NASDAQ:ENGN
US Market
Want to see ENGN full AI Analyst Report?

Compare enGene Holdings (ENGN) vs. Competitors

307 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
enGene Holdings
$8.07
$107.85M
-5.39
-61.67%
3 Buy
8 Hold
0 Sell
Moderate Buy
Tvardi Therapeutics
$3.39
$36.12M
-1.10
-86.12%
3 Buy
2 Hold
1 Sell
Moderate Buy
Capricor Therapeutics
$34.70
$1.68B
-12.86
163.49%
8 Buy
0 Hold
0 Sell
Strong Buy
Replimune Group
$2.17
$426.07M
-3.16
-43.85%
0 Buy
4 Hold
3 Sell
Moderate Sell
Immuneering
$5.56
$324.78M
-4.31
219.75%
5 Buy
0 Hold
0 Sell
Strong Buy
Contineum Therapeutics, Inc. Class A
$13.53
$500.60M
-8.43
249.61%
5 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ENGN
enGene Holdings
1.61
-2.43
-60.15%
TVRD
Tvardi Therapeutics
3.85
-28.87
-88.23%
CAPR
Capricor Therapeutics
29.01
17.89
160.88%
REPL
Replimune Group
5.16
-3.30
-39.01%
IMRX
Immuneering
5.02
3.54
239.19%
CTNM
Contineum Therapeutics, Inc. Class A
13.39
9.53
246.89%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts